Literature DB >> 122639

Miconazole in coccidioidomycosis.

H B Levine1.   

Abstract

The epidemiology of Coccidioides immitis is described with respect to annual infection rates and differing ethnic susceptibilities to the infection. A trial of miconazole in infected mice produced 100% survival in conditions which normally kill 100% of animals, probably by drastically reducing the rate of fungal multiplication in the lung. The fungal endospore, the form of the dimorphic fungus found predominantly in host tissue is more sensitive to miconazole than is the mycelial form. Data are presented from 14 human patients, some moribund and comatose, all of whom had failed to respond to existing therapy. There was objective evidence of improvement in eight, and a subjective impression of improvement in the majority. One patient failed to respond and three have equivocal results.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122639      PMCID: PMC1542870     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  4 in total

1.  Treatment of disseminated coccidioidomycosis with miconazole.

Authors:  J P Sung
Journal:  West J Med       Date:  1976-01

2.  Dermal sensitivity to Coccidioides immitis. A comparison of responses elicited in man by spherulin and coccidioidin.

Authors:  H B Levine; A Gonzalez-Ochoa; D R Ten Eyck
Journal:  Am Rev Respir Dis       Date:  1973-03

Review 3.  Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man.

Authors:  D A Stevens; H B Levine; S C Deresinski
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

4.  Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro.

Authors:  H B Levine; D A Stevens; J M Cobb; A E Gebhardt
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.